The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.

The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.
复制标题

DOI:
10.3389/fonc.2021.696705
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Xu X
Xu X
中科院分区:
医学3区
文献类型:
--
作者:
Hu X;Zhu H;Shen Y;Zhang X;He X;Xu X

文献摘要

参考文献

被引文献

相似文献

肝细胞癌(HCC)是癌症相关死亡的第二大常见原因。索拉非尼被美国食品和药物管理局批准为晚期HCC患者的一线化疗药物。一部分晚期HCC患者可以从索拉非尼治疗中获益,但许多患者最终发展为索拉非尼耐药,导致预后不良。索拉非尼耐药的分子机制是复杂和不确定的。值得注意的是,非编码RNA(ncRNA),包括长ncRNA(lncRNA)、微小RNA(miRNAs)和环状RNA(circRNA),在肿瘤的发生和发展中起着关键作用。此外,越来越多的证据表明,ncRNA是索拉非尼耐药性发展的关键调节因子。本文就ncRNA影响肝癌索拉非尼耐药的分子机制和重要作用进行了系统的综述,并探讨了ncRNA作为肝癌新的预后标志物和治疗靶点的临床应用前景。
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death. Sorafenib is approved by the U.S. Food and Drug Administration to be a first-line chemotherapy agent for patients with advanced HCC. A portion of advanced HCC patients can benefit from the treatment with sorafenib, but many patients ultimately develop sorafenib resistance, leading to a poor prognosis. The molecular mechanisms of sorafenib resistance are sophisticated and indefinite. Notably, non-coding RNAs (ncRNAs), which include long ncRNAs (lncRNAs), microRNAs (miRNAs) and circular RNAs (circRNAs), are critically participated in the occurrence and progression of tumors. Moreover, growing evidence has suggested that ncRNAs are crucial regulators in the development of resistance to sorafenib. Herein, we integrally and systematically summarized the molecular mechanisms and vital role of ncRNAs impact sorafenib resistance of HCC, and ultimately explored the potential clinical administrations of ncRNAs as new prognostic biomarkers and therapeutic targets for HCC.
MiR-21 通过 PTEN/Akt 通路抑制自噬来介导肝细胞癌细胞索拉非尼耐药。
DOI: 10.18632/oncotarget.4814
发表时间: 2015-10-06
期刊: Oncotarget
影响因子: --
作者:
He C;Dong X;Zhai B;Jiang X;Dong D;Li B;Jiang H;Xu S;Sun X
通讯作者: Sun X
miR-124调节肝癌干细胞扩增和索拉非尼耐药
DOI: 10.1016/j.yexcr.2020.112162
发表时间: 2020-09-15
影响因子: 3.7
作者:
Feng, Yun;Jiang, Weiliang;Dong, Yuwei
通讯作者: Dong, Yuwei
DOI: 10.7150/ijms.37427
发表时间: 2019-01-01
影响因子: 3.6
作者:
Cai, Hongqiao;Yang, Yang;Ji, Bai
通讯作者: Ji, Bai
DOI: 10.1158/1078-0432.ccr-16-1464
发表时间: 2017-07-15
影响因子: 11.5
作者:
Fornari, Francesca;Pollutri, Daniela;Gramantieri, Laura
通讯作者: Gramantieri, Laura
DOI: 10.1016/j.gene.2012.12.106
发表时间: 2013-04-15
期刊: GENE
影响因子: 3.5
作者:
Costantini, S.;Di Bernardo, G.;Colonna, G.
通讯作者: Colonna, G.